Sfoglia per AUTORE
CAPPUZZO F
Collezione AOU San Luigi di Orbassano

  

Items : 11

Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis Of Solid Dominant Stage I Lung Adenocarcinoma. in Clinical lung cancer / Clin Lung Cancer. 2025 Jan 9:S1525-7304(25)00002-6. doi: 10.1016/j.cllc.2025.01.001.
2025
AOU San Luigi di Orbassano

Tajè R; Ambrogi V; Tacconi F; Gallina FT; Alessandrini G; Forcella D; Buglioni S; Visca P; Patirelis A; Cecere FL; Melis E; Vidiri A; Sperduti I; Cappuzzo F; Novello S; Caterino M; Facciolo F;

MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database. in ESMO open / ESMO Open. 2024 Sep;9(9):103680. doi: 10.1016/j.esmoop.2024.103680. Epub 2024 Aug 29.
2024
ASL Asti
AOU San Luigi di Orbassano

Baldini E; Di Micco C; Banini M; Calvetti L; Leone F; Carta A; Pignataro D; Pozzessere D; Muscolino P; Bria E; Citarella F; Pilotto S; Cortinovis D; Gariazzo E; Pelizzari G; Roca E; Galetta D; Sini C; Delmonte A; Bulotta A; Occhipinti M; Minuti G; Cappuzzo F; Reale ML; Passiglia F; Favaretto A; Malapelle U; Novello S; Pasello G; et alii...

Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Oct;174:200-211. doi: 10.1016/j.ejca.2022.07.026. Epub 2022 Aug 28.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Bria E; Rossi G; Rossi A; Di Maio M; Bareggi C; Osman G; Cortinovis D; Cappuzzo F; Del Conte A; Pilotto S; Sergi C; Gregorc V; Ghilardi L; Scotti V; Tiseo M; Martelli O; Maiello E; Rigutto A; Galetta D; Castellana S; Trombetta D; Gobbini E; Muscarella LA; Tabbò F; Volante M; Scagliotti GV; Graziano P; Novello S; Righi L; et alii...

HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of ?-catenin-FGF18 pathway. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2022 Mar 11;41(1):91. doi: 10.1186/s13046-022-02266-9.
2022
AOU San Luigi di Orbassano

Guo K; Ma Z; Zhang Y; Han L; Shao C; Feng Y; Gao F; Di S; Zhang Z; Zhang J; Tabbò F; Ekman S; Suda K; Cappuzzo F; Han J; Li X; Yan X;

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ? 50% and Their Relationship With Clinical Outcomes. in Clinical lung cancer / Clin Lung Cancer. 2020 Nov;21(6):498-508.e2. doi: 10.1016/j.cllc.2020.06.010. Epub 2020 Jun 21.
2020
AOU San Luigi di Orbassano

Cortellini A; Friedlaender A; Banna GL; Porzio G; Bersanelli M; Cappuzzo F; Aerts JGJV; Giusti R; Bria E; Cortinovis D; Grossi F; Migliorino MR; Galetta D; Passiglia F; Berardi R; Mazzoni F; Di Noia V; Signorelli D; Tuzi A; Gelibter A; Marchetti P; Macerelli M; Rastelli F; Chiari R; Rocco D; Inno A; Di Marino P; Mansueto G; Zoratto F; et alii...

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ??50. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2020 Nov;69(11):2209-2221. doi: 10.1007/s00262-020-02613-9. Epub 2020 May
2020
AOU San Luigi di Orbassano

Cortellini A; Tiseo M; Banna GL; Cappuzzo F; Aerts JGJV; Barbieri F; Giusti R; Bria E; Cortinovis D; Grossi F; Migliorino MR; Galetta D; Passiglia F; Santini D; Berardi R; Morabito A; Genova C; Mazzoni F; Di Noia V; Signorelli D; Tuzi A; Gelibter A; Marchetti P; Macerelli M; Rastelli F; Chiari R; Rocco D; Gori S; De Tursi M; et alii...

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Mar;22(3):294-301. doi: 10.1007/s12094-019-02222-8. Epub 2019 Oct 19.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Novello S; Di Maio M; Tiseo M; Galetta D; Bria E; Rossi G; Tabbò F; Cortinovis D; Rizzo P; Delmonte A; Bareggi C; Del Conte A; Sergi C; Casartelli C; Gregorc V; Graziano P; Rossi A; Maiello E; Scotti V; Martelli O; Borra G; Riccardi F; Osman G; Cappuzzo F; Cecere F; Pilotto S; Ghilardi L; Bordi P; Gobbini E; et alii...

2019
AOU San Luigi di Orbassano

Facchinetti F; Pilotto S; Metro G; Baldini E; Bertolaccini L; Cappuzzo F; Delmonte A; Gasparini S; Inno A; Marchetti A; Passiglia F; Puma F; Ricardi U; Rossi A; Crinò L; Novello S;

2015
AOU San Luigi di Orbassano

Barni S; Maiello E; Di Maio M; Ardizzoni A; Cappuzzo F; Maranzano E; Novello S; Bennati C; Ori A; Rizzoli S; Crinò L;

Management of Italian patients with advanced non-small-cell lung cancer after second-line treatment: results of the longitudinal phase of the LIFE observational study. in Clinical lung cancer / Clin Lung Cancer. 2014 Sep;15(5):338-45.e1. doi: 10.1016/j.cllc.2014.04.004. Epub 2014 May 14.
2014
AOU San Luigi di Orbassano

de Marinis F; Ardizzoni A; Fontanini G; Grossi F; Cappuzzo F; Novello S; Santo A; Lorusso V; Cortinovis D; Iurlaro M; Galetta D; Gridelli C;

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Nov;25(11):2156-2162. doi: 10.1093/annonc/mdu384. Epub 2014 Aug 19.
2014
AOU San Luigi di Orbassano

Novello S; Besse B; Felip E; Barlesi F; Mazieres J; Zalcman G; von Pawel J; Reck M; Cappuzzo F; Ferry D; Carcereny E; Santoro A; Garcia-Ribas I; Scagliotti G; Soria JC;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte